Evidence map›Paper›PMID 24934831›Full record

ArticleHuman genetics2014

Next generation modeling in GWAS: comparing different genetic architectures.

Evangelina López de Maturana, Noelia Ibáñez-Escriche, Óscar González-Recio, Gaëlle Marenne, Hossein Mehrban, Stephen J Chanock, Michael E Goddard, Núria Malats

Open access · greenAbstract readComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in Human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2018
    Article
  5. Article
  6. Article
  7. Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Evangelina López de MaturanaGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), C/MelchorFernándezAlmagro, 3, 28029, Madrid, Spain, melopezdm@cnio.es.
Noelia Ibáñez-Escriche
Óscar González-Recio
Gaëlle Marenne
Hossein Mehrban
Stephen J Chanock
Michael E Goddard
Núria Malats
Spanish National Cancer Research Centre · ESAgriBio · AUUniversitat de Lleida · ESDivision of Cancer Epidemiology and Genetics

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous advancement in genotyping technology has not been accompanied by the application of innovative statistical methods, such as multi-marker methods (MMM), to unravel genetic associations with complex traits. Although the performance of MMM has been widely explored in a prediction context, little is known on their behavior in the quantitative trait loci (QTL) detection under complex genetic architectures. We shed light on this still open question by applying Bayes A (BA) and Bayesian LASSO (BL) to simulated and real data. Both methods were compared to the single marker regression (SMR). Simulated data were generated in the context of six scenarios differing on effect size, minor allele frequency (MAF) and linkage disequilibrium (LD) between QTLs. These were based on real SNP genotypes in chromosome 21 from the Spanish Bladder Cancer Study. We show how the genetic architecture dramatically affects the behavior of the methods in terms of power, type I error and accuracy of estimates. Markers with high MAF are easier to detect by all methods, especially if they have a large effect on the phenotypic trait. A high LD between QTLs with either large or small effects differently affects the power of the methods: it impairs QTL detection with BA, irrespectively of the effect size, although boosts that of small effects with BL and SMR. We demonstrate the convenience of applying MMM rather than SMR because of their larger power and smaller type I error. Results from real data when applying MMM suggest novel associations not detected by SMR.

Indexed as

Computer SimulationAllelesBayes TheoremCase-Control StudiesGene FrequencyGenes, NeoplasmGenome-Wide Association StudyGenotyping TechniquesHispanic or LatinoHumansLinkage DisequilibriumPolymorphism, Single NucleotideQuantitative Trait LociUrinary Bladder Neoplasms

Identifiers

PMID24934831
OpenAlexW2076930955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.